Maximilian Pfau, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Philipp Mueller, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Leon von der Emde, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Moritz Lindner, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Ruth Hassenrik, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Philipp Möller, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Monika Fleckenstein, Alcon/Novartis (F), Alcon/Novartis (C), Bayer (F), Bayer (R), Carl Zeiss MediTec (F), CenterVue (F), Genentech/Roche (C), Genentech/Roche (F), Genentech/Roche (R), Heidelberg Engineering (F), Heidelberg Engineering (R), Optos (F), US20140303013 pending (P);
Frank Holz, Acucela (F), Acucela (C), Allergan (F), Allergan (R), Bayer (F), Bayer (C), Bayer (R), Bioeq (F), Bioeq (C), Boehringer-Ingelheim (C), Carl Zeiss MediTec (F), Carl Zeiss MediTec (R), CenterVue (F), Genentech/Roche (F), Genentech/Roche (C), Genentech/Roche (R), Heidelberg Engineering (F), Heidelberg Engineering (C), Heidelberg Engineering (R), NightstarX (F), Novartis (F), Novartis (C), Novartis (R), Optos (F), Thea (C);
Steffen Schmitz-Valckenberg, Alcon/Novartis (C), Alcon/Novartis (F), Allergan (F), Allergan (R), Bayer (F), Bayer (R), Carl Zeiss MediTec (F), CenterVue (F), Formycon (F), Heidelberg Engineering (F), Heidelberg Engineering (R), Optos (F)